应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
01763 中国同辐
交易中 06-29 15:09:29
18.000
+0.700
+4.05%
最高
18.210
最低
17.430
成交量
8.48万
今开
17.730
昨收
17.300
日振幅
4.51%
总市值
57.60亿
流通市值
14.39亿
总股本
3.20亿
成交额
151.36万
换手率
0.11%
流通股本
7,997万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
中国同辐将于8月17日派发末期股息每股0.2264元
新浪港股 · 06-22
中国同辐将于8月17日派发末期股息每股0.2264元
中国同辐(01763)将于8月17日派发末期股息每股0.2264元
智通财经 · 06-18
中国同辐(01763)将于8月17日派发末期股息每股0.2264元
中国同辐宣派末期股息每股0.2264元，派息日8月17日
公告速递 · 06-18
中国同辐宣派末期股息每股0.2264元，派息日8月17日
中国同辐宣派末期股息每股0.2264元，预计8月17日前派发
公告速递 · 06-18
中国同辐宣派末期股息每股0.2264元，预计8月17日前派发
中国同辐(01763)委任张国良为董事会法治委员会委员
智通财经 · 06-18
中国同辐(01763)委任张国良为董事会法治委员会委员
港股异动 | 中国同辐(01763)午后涨超5% 近日放射源研发生产基地(二期)成功获批辐射安全许可证
智通财经 · 06-11
港股异动 | 中国同辐(01763)午后涨超5% 近日放射源研发生产基地(二期)成功获批辐射安全许可证
智通港股早知道 | 美国5月CPI同比上涨4.2% 工信部：加强高端光电芯片和器件研发
智通财经 · 06-11
智通港股早知道 | 美国5月CPI同比上涨4.2% 工信部：加强高端光电芯片和器件研发
中国同辐启动加州锎-252、铯-137及镅-241生产项目
美股速递 · 06-10
中国同辐启动加州锎-252、铯-137及镅-241生产项目
中国同辐5月股份变动月报表，股本维持不变
公告速递 · 06-02
中国同辐5月股份变动月报表，股本维持不变
中国同辐(01763)：建议委任信永中和为核数师
智通财经 · 05-27
中国同辐(01763)：建议委任信永中和为核数师
中国同辐(01763)：建议委任张国良为非执行董事
智通财经 · 05-26
中国同辐(01763)：建议委任张国良为非执行董事
中国同辐(01763)附属公司中核高通及中国中原与邦德波尔签署《泰国次级标准化中子剂量实验室项目技术服务合同》
智通财经 · 05-08
中国同辐(01763)附属公司中核高通及中国中原与邦德波尔签署《泰国次级标准化中子剂量实验室项目技术服务合同》
中国同辐与中国核工业集团同Pondpol签署中子剂量学实验室项目合同
美股速递 · 05-08
中国同辐与中国核工业集团同Pondpol签署中子剂量学实验室项目合同
中国同辐2026年4月股份变动月报：股本结构保持稳定
公告速递 · 05-05
中国同辐2026年4月股份变动月报：股本结构保持稳定
中国同辐2025年收入同比微降 核医学与辐照业务多点推进
公告速递 · 04-22
中国同辐2025年收入同比微降 核医学与辐照业务多点推进
异动解读 | 中国同辐发布强劲2025年业绩，盘中大涨6.45%
异动解读 · 03-30
异动解读 | 中国同辐发布强劲2025年业绩，盘中大涨6.45%
中国同辐2025毛利率提至50.4%创新高，“十五五”良好开局蓄势待发
金吾财讯 · 03-30
中国同辐2025毛利率提至50.4%创新高，“十五五”良好开局蓄势待发
中国同辐(01763)：原子高科预计年度归属于挂牌公司股东的净利润同比下降12.65%
智通财经 · 03-28
中国同辐(01763)：原子高科预计年度归属于挂牌公司股东的净利润同比下降12.65%
中国同辐(01763)发布年度业绩，归母净利润3.27亿元 同比下降19.5%
智通财经 · 03-28
中国同辐(01763)发布年度业绩，归母净利润3.27亿元 同比下降19.5%
中国同辐(01763)：签订股权转让协议 进一步拓展无损检测业务版图
智通财经 · 03-19
中国同辐(01763)：签订股权转让协议 进一步拓展无损检测业务版图
加载更多
公司概况
公司名称：
中国同辐
所属市场：
SEHK
上市日期：
--
主营业务：
中国同辐股份有限公司是一家主要从事放射性药品、医用和工业用放射源产品的研究、开发、制造及销售的中国公司。该公司经营五个业务分部。药品分部主要提供各种显像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪，以及体外诊断试剂及药盒。放射源产品分部主要提供医疗、工业等领域用各种放射源产品及相关技术服务。辐照分部主要提供辐照灭菌服务。放射治疗设备及相关服务分部主要生产放疗设备。其他业务分部主要提供进口放射源、医用核素、进口放射性药品等产品的贸易服务。
发行价格：
--
{"stockData":{"symbol":"01763","market":"HK","secType":"STK","nameCN":"中国同辐","latestPrice":18,"timestamp":1782716667602,"preClose":17.3,"halted":0,"volume":84800,"delay":0,"changeRate":0.0404624277456647,"floatShares":79968800,"shares":320000000,"eps":1.02,"marketStatus":"交易中","change":0.7,"latestTime":"06-29 15:09:29","open":17.73,"high":18.21,"low":17.43,"amount":1513646,"amplitude":0.045087,"askPrice":18,"askSize":3400,"bidPrice":17.92,"bidSize":600,"shortable":0,"etf":0,"ttmEps":1.139076,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782720600000},"marketStatusCode":2,"adr":0,"listingDate":1530806400000,"exchange":"SEHK","adjPreClose":17.3,"dividendRate":0.019427,"openAndCloseTimeList":[[1782696600000,1782705600000],[1782709200000,1782720000000]],"volumeRatio":0.808954,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01763","defaultTab":"news","newsList":[{"id":"2645701430","title":"中国同辐将于8月17日派发末期股息每股0.2264元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645701430","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645701430?lang=zh_cn&edition=full","pubTime":"2026-06-22 08:22","pubTimestamp":1782087720,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 中国同辐（01763）发布公告，该公司将于2026年8月17日派发末期股息每股0.2264元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-06-22/doc-iniefuxz7107887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4585","01763","BK1222","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644508216","title":"中国同辐(01763)将于8月17日派发末期股息每股0.2264元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644508216","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644508216?lang=zh_cn&edition=full","pubTime":"2026-06-18 23:13","pubTimestamp":1781795638,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，该公司将于2026年8月17日派发末期股息每股0.2264元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VIG","BK4585","01763","BK1222","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170449330","title":"中国同辐宣派末期股息每股0.2264元，派息日8月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=1170449330","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170449330?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:55","pubTimestamp":1781794558,"startTime":"0","endTime":"0","summary":"中国同辐发布更新公告，将截至2025年12月31日止年度的末期股息定为每股0.2264元人民币。公司预设派发货币为港元，折合每股0.2604港元，汇率按1人民币兑1.150356港元计算。除净日定为2026年6月23日，为符合获取股息分派而递交股份过户文件的最后时限为6月24日16:30。股份过户登记将自6月25日至6月30日暂停办理，权益登记日为6月30日。股息最终派发日为2026年8月17日。代扣所得税方面，非中国内地登记地址的非居民企业股东将按10%税率代扣企业所得税。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"中国同辐宣派末期股息每股0.2264元，派息日8月17日","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129735433","title":"中国同辐宣派末期股息每股0.2264元，预计8月17日前派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1129735433","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129735433?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:35","pubTimestamp":1781793342,"startTime":"0","endTime":"0","summary":"中国同辐(01763)公布，2025年度股东会已审议批准派发截至2025年12月31日止年度的末期股息，每股人民币0.2264元（含税），合计派发约7241.97万元。\n此次股息将以人民币向內资股持有人支付，H股持有人则按港元收取。H股股息换算汇率为中国人民银行于年度股东会日期前五个工作日港元兑人民币平均中间价（1.00港元兑人民币0.869296元），折算后每股H股派发0.2604港元（含税）。公司预计将于2026年8月17日（星期一）前向全体股东完成派发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国同辐宣派末期股息每股0.2264元，预计8月17日前派发","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644587084","title":"中国同辐(01763)委任张国良为董事会法治委员会委员","url":"https://stock-news.laohu8.com/highlight/detail?id=2644587084","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644587084?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:32","pubTimestamp":1781793137,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，于2026年6月18日，董事会决议委任张国良先生为董事会法治委员会委员及董事会科技创新委员会委员，任期至第四届董事会届满之日止。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642061884","title":"港股异动 | 中国同辐(01763)午后涨超5% 近日放射源研发生产基地(二期)成功获批辐射安全许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2642061884","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642061884?lang=zh_cn&edition=full","pubTime":"2026-06-11 13:40","pubTimestamp":1781156433,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国同辐午后涨超5%，截至发稿，涨4.71%，报18.02港元，成交额121.64万港元。消息面上，中国同辐发布公告，近日，中国同辐旗下附属公司成都中核高通同位素股份有限公司的放射源研发生产基地项目(二期)建成，并成功获批辐射安全许可证许可项目增项，锎-252、铯-137、镅-241等放射源生产线正式投产，全方位满足市场多元化需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","01763","VXUS","BK1222","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642744524","title":"智通港股早知道 | 美国5月CPI同比上涨4.2% 工信部：加强高端光电芯片和器件研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2642744524","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642744524?lang=zh_cn&edition=full","pubTime":"2026-06-11 07:42","pubTimestamp":1781134977,"startTime":"0","endTime":"0","summary":"热门中概股多数下跌，纳斯达克中国金龙指数跌0.28%。美国5月CPI同比上涨4.2%美国劳工部10日发布的数据显示，受能源价格上涨推动，美国5月消费者价格指数同比上涨4.2%，创2023年5月以来新高。其他在产锂精矿工厂的运营不受此次事件影响。报道称，蚂蚁、General Atlantic和Silver Lake代表均不予置评。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2111349929.HKD","IE00BKPKM429.USD","LU0109392836.USD","LU2463028550.USD","LU2089284900.SGD","LU2106854487.HKD","LU0880133367.SGD","IE00B775H168.HKD","LU0683600562.USD","LU0784383803.USD","LU0061475181.USD","BK4533","LU0689472784.USD","LU0234570918.USD","LU0354030438.USD","LU1261432733.SGD","BK4612","LU1813983027.USD","IE00BMPRXN33.USD","LU1064131342.USD","BK1574","LU1712237335.SGD","LU1803068623.USD","LU2720916845.USD","LU2462591277.SGD","LU0738911758.USD","LU0444973449.USD","SG9999011175.SGD","LU1718418525.SGD","LU2272731600.USD","LU1152091168.USD","LU0545039389.USD","HK0000914686.HKD","LU2168563687.JPY","BK1155","LU0315179316.USD","LU2954938101.SGD","LU2095319765.USD","LU2361044949.HKD","IE00B19Z9Z06.USD","LU0661504455.SGD","IE00B031HY20.USD","SG9999015952.SGD","SG9999015945.SGD","QCOM","SGXZ81514606.USD","LU1852331112.SGD","IE00BMPRXQ63.HKD","LU0965509101.SGD","LU2756315318.SGD","BK1191","LU2750360641.GBP","LU2210150020.SGD","LU1960683339.HKD","QCML","LU1162221912.USD","LU2357627491.SGD","LU0256863811.USD","LU0965508806.USD","LU0097036916.USD","LU1815333072.USD","LU0048584097.USD","LU1037948541.HKD","LU1670627923.USD","LU1037948897.HKD","LU2272731865.HKD","IE00B5MMRT66.SGD","LU0788109477.HKD","LU2065169927.USD","LU1917777945.USD","LU1923623000.USD","LU2063271972.USD","LU1153585028.USD","LU2242650005.HKD","LU0354030511.USD","LU1670711123.USD","LU2602419157.SGD","LU1066051498.USD","LU2125909247.SGD","LU2764263039.SGD","LU0345768740.USD","LU0957808578.USD","LU2237443978.SGD","IE00BN29S564.USD","IE0001KFT4U8.USD","LU0784385170.HKD","00658","LU1670710588.SGD","LU0170899867.USD","LU2637965513.SGD","LU2471134796.USD","HK0000914660.USD","LU1003077747.HKD","LU1935043023.USD","LU2237443549.SGD","LU0080751232.USD","LU1084165304.USD","IE00BBT3K403.USD","LU0472753341.HKD","LU2462591350.SGD","LU1992135472.HKD","LU1670710661.SGD","MULL","LU2360106780.USD","LU1993786604.SGD","LU1242518931.SGD","IE00BVYPNP33.GBP","LU2065171311.SGD","LU2210149790.SGD","BK4566","LU2417539215.USD","LU0314104364.USD","LU1226287529.USD","LU0210536198.USD","LU1232071149.USD","LU1242518857.USD","LU1226287792.SGD","LU2279689827.SGD","LU0203201768.USD","BK1586","LU2298321311.HKD","IE00B894F039.SGD","BK0182","LU2471134879.HKD","BK1179","LU0859254822.USD","IE00B19Z3B42.SGD","LU2065171402.SGD","LU0210528500.USD","SG9999000418.SGD","IE00BKDWB100.SGD","BK0233","IE00BFSS7M15.SGD","IE00BLSP4452.SGD","LU1035775433.USD","LU1244550577.SGD","MUU","LU1868837136.USD","LU2756315664.SGD","LU0106261372.USD","LU0965509283.SGD","LU1868836914.USD","LU0444971666.USD","BK0077","BK4605","LU1008478684.HKD","LU1066053197.SGD","LU2473716301.USD","LU0203347892.USD","BK4554","IE0002270589.USD","LU0345769128.USD","LU0348723411.USD","LU1127390331.HKD","LU2592432038.USD","IE00BK4W5M84.HKD","LU0234572021.USD","IE00B7KXQ091.USD","IE00BVYPNV92.GBP","IE00BMCWC346.EUR","LU1267930730.SGD","LU1720051108.HKD","BK0028","SG9999001440.SGD","LU0345770993.USD","BK1518","LU0642271901.SGD","LU2039709279.SGD","00354","BK0155","09966","LU2237438978.USD","BK1521","LU2265009873.SGD","AVS","LU1868836591.USD","BK1515","MU","LU1814569148.SGD","LU2505996509.AUD","LU0353189680.USD","LU0823434583.USD","IE00BLSP4239.USD","BK4553","LU1951186391.HKD","LU2236285917.USD","GB00BDT5M118.USD","LU2931357623.SGD","LU2286300806.USD","BK4532","LU2237443382.USD","LU0912757837.SGD","LU2430703178.SGD","LU2168564065.EUR","LU2361044865.SGD","BK0196","LU0203345920.USD","LU0310799852.SGD","LU2322448957.HKD","LU2083900584.USD","LU2213496289.HKD","LU0316494557.USD","LU2420271590.USD","IE00B3S45H60.SGD","LU0868494708.USD","BK4581","HK0000165453.HKD","LU1732800096.USD","LU2065170008.USD","LU0466842654.USD","LU1645745479.HKD","LU0011850046.USD","LU2430703095.HKD","LU0820561818.USD","LU0096362180.USD","LU0553294199.USD","LU2237443895.HKD","LU1670756490.USD","LU2746668461.USD","IE00B42XCP33.USD","LU0985320562.USD","AVGO","LU0795875086.SGD","IE00BJTD4V19.USD","LU0072913022.USD","LU1992135399.USD","IE00B3PB1722.GBP","LU2471134952.CNY","LU1988902786.USD","LU1069344957.HKD","LU0251132253.USD","IE00B19Z3581.USD","BK1526","LU1323610961.USD","LU0061474705.USD","IE00BGHQF631.EUR","LU2242649171.HKD","LU0943347566.SGD","LU2347655073.USD","LU1935043536.SGD","BK4543","BK0183","LU0053666078.USD","LU0820562030.AUD","LU0006306889.USD","LU1366333091.USD","LU1868837300.USD","LU2237443465.HKD","LU0689626769.HKD","LU2860962120.EUR","AVGG","LU0417517546.SGD","LU2461242641.AUD","LU2133065610.SGD","BK1205","IE0008368742.USD","LU2211815571.USD","IE00BZ9MQY76.HKD","LU2250418816.HKD","LU2237957811.SGD","LU0211328371.USD","LU1823568750.SGD","LU0276348264.USD","LU2355687059.USD","LU2471134523.USD","LU0724617625.USD","SGXZ23171101.USD","LU2108987350.USD","LU2764262908.HKD","LU1989772840.SGD","LU1951200564.SGD","SG9999015978.USD","LU0140636845.USD","LU1548497426.USD","LU2750360997.AUD","LU1400636657.SGD","LU0187121727.USD","LU1720051017.SGD","IE00BVYPNW00.USD","LU2237443622.USD","IE00BZ08YR35.GBP","IE00BGHQDM52.EUR","LU1202635105.USD","LU2462157665.USD","BK4588","LU0124676726.USD","LU0511384066.AUD","LU0061474960.USD","LU2125909593.SGD","LU2041044095.USD","LU1935042488.USD","01277","LU1328277881.USD","LU1316542783.SGD","01763","LU0942090050.USD","MUD","IE0034235303.USD","LU0198837287.USD","LU0289961442.SGD","LU0861579265.USD","BK4561","LU0823434740.USD","LU2271345857.HKD","LU0211327993.USD","LU0266013472.USD","LU0345769631.USD","LU2023250843.SGD","LU2360032135.SGD","IE00B7SZLL34.SGD","IE00BJLML261.HKD","LU1301847155.USD","IE00BQXX3D17.EUR","IE0008369823.USD","LU0949170772.SGD","IE00B775SV38.USD","LU1934455194.USD","AVL","LU2458330243.SGD","LU2211814178.USD","LU0708995401.HKD","LU0238689110.USD","LU0868494617.USD","IE00B543WZ88.USD","IE00BWXC8680.SGD","LU1629891620.HKD","LU0308772762.SGD","IE00BMPRXR70.SGD","LU1923622614.USD","LU2237957902.USD","LU2456880835.USD","LU0784384876.USD","LU2430703251.USD","LU2433249047.HKD","LU1670711040.USD","LU1280957306.USD","LU2403377893.USD","LU1226288253.USD","SGXZ51526630.SGD","LU1226288170.HKD","LU1935042215.USD","LU0820561909.HKD","LU2322448791.USD","00031","LU2357305700.SGD","BK1546","LU0082616367.USD","BK1161","IE00BYV24P56.USD","BK1589","LU1807302812.USD","LU2048586759.USD","LU0174119429.USD","01093","LU0069063385.USD","LU2023250504.SGD","LU2543165471.USD","LU1951198990.SGD","LU1691799644.USD","LU1642822529.SGD","IE00BJJMRY28.SGD","LU0256863902.USD","LU1732799900.SGD","LU1046421795.USD","LU2089985449.USD","LU0203202063.USD","LU0158827781.USD","BK4598","LU0353189763.USD","LU1778281490.HKD","LU1989764664.SGD","LU0672654240.SGD","LU2028103732.USD","LU0225283273.USD","IE00BQXX3F31.USD","LU1267930813.SGD","LU1400636491.USD","LU1674673428.USD","BK4141","BK4534","AVGX","LU0158827948.USD","SG9999003800.SGD","IE00B1BXHZ80.USD","LU0345770308.USD","IE0034235188.USD","IE0004445015.USD","QCMU","LU0081259029.USD","LU1989772923.USD","IE00BN8TJ469.HKD","LU1119994496.HKD","LU0157215616.USD","LU2168564149.EUR","BK1178","LU0792757196.USD","LU0964807845.USD","LU0072462426.USD","LU1935042991.SGD","LU1815336760.USD","LU2746668974.SGD","BK4527","LU1914381329.SGD","LU0345768153.USD","IE00BZ08YS42.EUR","LU1066051811.HKD","LU0949170426.SGD","LU1244550494.USD","LU1551013342.USD","LU0476273544.USD","LU1803068979.SGD","LU0057025933.USD","SG9999002224.SGD","LU2168564495.EUR","LU2089283258.USD","LU0787776722.HKD","LU0323591593.USD","LU2347655156.SGD","LU0314109678.HKD","LU2896262040.SGD","LU2487616109.SGD","IE00BK4W5L77.USD","IE0004445239.USD","IE0009356076.USD","LU0786609619.USD","AVGW","LU1934455277.USD","LU2272731782.SGD","SGXZ99366536.SGD","002466","LU0640476718.USD","LU2023250330.USD","LU1623119135.USD","LU0326950275.SGD","BK4585","SG9999002232.USD","BK4515","IE00BJTD4N35.SGD","LU1267930490.SGD","LU1989764748.USD","LU2764263203.CNY","LU1974910355.USD","LU0079474960.USD","LU1674673691.USD","BK0197","CHSTY","LU0154236417.USD","SG9999015986.USD","BK4575","LU0957791311.USD","IE00BJJMRX11.SGD","LU2054465674.USD","BK1222","LU0320765646.SGD","LU0056508442.USD","LU2505996681.GBP","AVGU","LU1226287875.USD","SG9999004220.SGD","IE00BKVL7J92.USD","LU0726765562.USD","LU0501845795.SGD","IE00BVYPNQ40.USD","LU0784385840.USD","IE00BSNM7G36.USD","LU2125154778.USD","LU0965509010.AUD","LU1804176565.USD","LU1551013425.SGD","IE00BFSS8Q28.SGD","LU0979878070.USD","LU1152091754.HKD","LU0215105999.USD","LU2023251221.USD","LU2264538146.SGD","SG9999004303.SGD","BK4551","IE00B19Z9P08.USD","LU0109391861.USD","BK4573","QCMD","IE00B4JS1V06.HKD","LU2999663052.SGD","LU2168564222.USD","LU1066051225.USD","LU0719512351.SGD","LU2125154935.USD","LU1934455863.HKD","LU1496350502.SGD","LU2087625088.SGD","IE00BQXX3C00.GBP","LU2247934214.USD","LU1400636574.HKD","LU0889566641.SGD","LU2244417387.USD","LU2361045086.USD","LU1868836757.USD","LU0096364046.USD","LU0070217475.USD","IE00B1XK9C88.USD","IE00BZ1G4Q59.USD","LU0289739343.SGD","LU0127658192.USD","LU1670628061.USD","LU0795875169.SGD","LU1145028129.USD","LU0320765059.SGD","IE00BZ08YT58.USD","BK4512","LU0889565833.HKD","IE00BDGV0183.EUR","HK0000532082.HKD","LU2458330169.SGD","LU0143551892.USD","LU2360108059.USD","LU1366192091.USD","LU0274383776.USD","IE0005OL40V9.USD","09696","BK4604","BK4579","LU0067412154.USD","SG9999001424.SGD","IE00B5949003.HKD","LU1244550221.USD","LU0133085943.USD","LU0210533765.USD","LU2092937221.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141285835","title":"中国同辐启动加州锎-252、铯-137及镅-241生产项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1141285835","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141285835?lang=zh_cn&edition=full","pubTime":"2026-06-10 22:21","pubTimestamp":1781101280,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司已正式启动其生产设施，开始制造加州锎-252、铯-137以及镅-241等关键放射性同位素。此举标志着公司在放射性同位素生产领域迈出了重要一步。\n这些同位素在工业、医疗及科研领域具有广泛且关键的应用。新项目的投产不仅有望提升国内相关材料的供应保障能力，也可能为公司在特种材料市场开辟新的增长路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144216272","title":"中国同辐5月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1144216272","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144216272?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:38","pubTimestamp":1780389534,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司于2026年6月2日更新了截至2026年5月31日的股份变动月报表。本次月报显示，公司各类股本保持稳定，未出现新增发行、购回、注销或库藏股变动。\\n\\n公告数据显示，截至报告期末，公司法定注册股本合计为人民币319,874,900元。其中，H股数量为79,968,800股，内资股数量为239,906,100股，面值均为人民币1元。报告期内，所有已发行股份总数和库存股份数目均无变化。\\n\\n本月报由联席公司秘书王仓忍代表董事会签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638525969","title":"中国同辐(01763)：建议委任信永中和为核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2638525969","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638525969?lang=zh_cn&edition=full","pubTime":"2026-05-27 06:17","pubTimestamp":1779833876,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，信永中和(香港)会计师事务所有限公司目前为本公司的核数师，负责审计及审阅本公司根据国际财务报告准则编制的财务会计报告。委任信永中和为本公司截至2026年12月31日止财政年度的核数师须待股东于2025年度股东会上以普通决议案形式审议及批准后方可作实。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446320.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638543409","title":"中国同辐(01763)：建议委任张国良为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2638543409","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638543409?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:45","pubTimestamp":1779806737,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，马晓宇女士因工作职务调整原因而辞任公司执行董事、董事会法治委员会委员及董事会科技创新委员会委员，自2026年5月26日起生效。于2026年5月26日，董事会决议建议委任张国良先生为公司第四届董事会非执行董事，任期自股东于公司股东会审议通过之日起至第四届董事会届满之日止。上述委任须待股东于股东会上批准后生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633045088","title":"中国同辐(01763)附属公司中核高通及中国中原与邦德波尔签署《泰国次级标准化中子剂量实验室项目技术服务合同》","url":"https://stock-news.laohu8.com/highlight/detail?id=2633045088","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633045088?lang=zh_cn&edition=full","pubTime":"2026-05-08 22:44","pubTimestamp":1778251440,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，近日，中国同辐附属公司成都中核高通同位素股份有限公司及中国中原对外工程有限公司与邦德波尔分析有限公司签署《泰国次级标准化中子剂量实验室项目技术服务合同》。在本项目下，中核高通主要负责向邦德波尔提供所需产品及相关服务，中国中原则主要承担项目管理及监督职能，且不参与相关产品及服务的提供。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GB00BDT5M118.USD","BK4612","LU1084165304.USD","LU0079474960.USD","BK4598","LU2247934214.USD","BK4573","LU1823568750.SGD","BK4588","BK4532","LU1069344957.HKD","BK4561","LU0868494708.USD","LU1244550221.USD","01763","LU1035775433.USD","BK4579","IE00BSNM7G36.USD","SG9999001424.SGD","SG9999015978.USD","BK4581","BK4512","IE00BGHQDM52.EUR","SG9999002232.USD","SG9999002224.SGD","LU1119994496.HKD","LU0081259029.USD","LU1046421795.USD","LU1261432733.SGD","SG9999015945.SGD","QCML","IE00BVYPNQ40.USD","QCMU","QCMD","BK4534","LU0061475181.USD","BK4141","LU1244550494.USD","LU1244550577.SGD","BK4554","LU2023250504.SGD","BK1222","BK4585","BK4515","BK4605","LU2106854487.HKD","LU1496350502.SGD","BK4604","LU0868494617.USD","SG9999015952.SGD","LU1974910355.USD","LU1917777945.USD","LU0942090050.USD","IE00BVYPNP33.GBP","SG9999015986.USD","BK4527","BK4575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102556769","title":"中国同辐与中国核工业集团同Pondpol签署中子剂量学实验室项目合同","url":"https://stock-news.laohu8.com/highlight/detail?id=1102556769","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102556769?lang=zh_cn&edition=full","pubTime":"2026-05-08 22:40","pubTimestamp":1778251213,"startTime":"0","endTime":"0","summary":"中国同辐（CIRC）与中国核工业集团已同Pondpol公司签署协议，共同承建中子剂量学实验室项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179499891","title":"中国同辐2026年4月股份变动月报：股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1179499891","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179499891?lang=zh_cn&edition=full","pubTime":"2026-05-05 16:42","pubTimestamp":1777970541,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司于2026年5月5日发布截至2026年4月30日止的证券变动月报表。报告显示，公司期内各类股份未发生新增发行、购回或注销，股本保持稳定。截至报告期末，公司确认其股本结构稳健，遵循相关法律法规及香港联合交易所有限公司《上市规则》的规定。本次公告由联席公司秘书王仓忍签署。公司强调，其所有证券发行与股份变动事宜均严格遵守上市规范，并获得董事会正式授权批准。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120925709","title":"中国同辐2025年收入同比微降 核医学与辐照业务多点推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1120925709","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120925709?lang=zh_cn&edition=full","pubTime":"2026-04-22 06:46","pubTimestamp":1776811601,"startTime":"0","endTime":"0","summary":"中国同辐股份有限公司在2025年度深耕核技术应用与同位素产业链，实现全年营业收入人民币71.88亿元，同比下降5.1%，主要受大型器械集采延缓及核医疗设备收入回落等因素影响。合并口径下利润总额为人民币10.04亿元，同比下降3.9%；年内净利润为人民币6.65亿元，同比下降24.4%。其中，归属于公司股东的净利润为人民币3.27亿元，同比下降19.5%，母公司财务口径下净利润为人民币4.574亿元，同比下降12.5%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"中国同辐2025年收入同比微降 核医学与辐照业务多点推进","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153919300","title":"异动解读 | 中国同辐发布强劲2025年业绩，盘中大涨6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153919300","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153919300?lang=zh_cn&edition=full","pubTime":"2026-03-30 09:33","pubTimestamp":1774834394,"startTime":"0","endTime":"0","summary":"中国同辐今日盘中股价大幅上涨6.45%，市场表现活跃。消息面上，公司于盘前发布了2025年度业绩报告，多项财务指标表现亮眼。报告显示，公司整体毛利率提升至50.4%，创下新高；扣除一次性补税影响后，归母净利润同比增长12.5%。此外，放射源业务收入同比增长12.4%，出口收入同比大幅增长59.4%，展现出强劲的增长动力。公司还宣布派发现金股息，持续回报股东。这份强劲的业绩报告和积极的未来展望，显著提振了市场信心，成为推动股价上涨的主要因素。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623361201","title":"中国同辐2025毛利率提至50.4%创新高，“十五五”良好开局蓄势待发","url":"https://stock-news.laohu8.com/highlight/detail?id=2623361201","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623361201?lang=zh_cn&edition=full","pubTime":"2026-03-30 09:04","pubTimestamp":1774832664,"startTime":"0","endTime":"0","summary":"受子公司一次性补缴税费及滞纳金影响，报告期归属母公司净利润3.27亿元；扣除补税影响后，归母净利润4.57亿元，同比增长12.5%。公司整体毛利率提升至50.4%，同比提高1.8个百分点；营业成本同比下降8.4%，主要系呼吸检测产品原料实现国产化替代，销售费用同比下降10.7%，盈利质量与经营效率显著优化。2025年度拟共宣派现金股息每股0.3071元，合计约9823万元，持续回报股东。放射源业务实现收入8.1亿元，同比增长12.4%，毛利率大幅提升至50.25%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977612","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622871362","title":"中国同辐(01763)：原子高科预计年度归属于挂牌公司股东的净利润同比下降12.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622871362","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622871362?lang=zh_cn&edition=full","pubTime":"2026-03-28 00:55","pubTimestamp":1774630556,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，本公司的附属公司原子高科预计截至2025年12月31日止年度归属于挂牌公司股东的净利润为2.59亿元，相比上年同期减少3749.39万元，降幅12.65%。变动原因主要是受参股公司深圳市中核海得威生物科技有限公司归母净利润减少影响，公司本年度投资收益同比下降。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"中国同辐(01763)：原子高科预计年度归属于挂牌公司股东的净利润同比下降12.65%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622879796","title":"中国同辐(01763)发布年度业绩，归母净利润3.27亿元 同比下降19.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622879796","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622879796?lang=zh_cn&edition=full","pubTime":"2026-03-28 00:42","pubTimestamp":1774629772,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布截至2025年12月31日止年度业绩，该集团取得收益人民币71.88亿元(单位下同)，同比减少5.11%;公司权益股东应占利润3.27亿元，同比减少19.48%;每股盈利1.02元，拟派发末期现金股息每股0.2264元。公告称，营业收入下降主要受甲类大型医疗装备集采延迟导致核医疗装备收入下降影响。净利润6.645亿元，同比下降24.4%，归母净利润3.27亿元，同比下降19.5%。扣除附属公司补缴税费及滞纳金影响，归母净利润4.57亿元，同比增长12.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620223267","title":"中国同辐(01763)：签订股权转让协议 进一步拓展无损检测业务版图","url":"https://stock-news.laohu8.com/highlight/detail?id=2620223267","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620223267?lang=zh_cn&edition=full","pubTime":"2026-03-19 21:04","pubTimestamp":1773925467,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐 发布公告，3月19日，中国同辐附属公司成都中核高通同位素股份有限公司签署《股权转让协议》，收购湖南汇丰工程检测有限公司51%股权。中核高通在国内无损检测放射源市场占据主导地位，拥有绝大多数市场份额。本次交易是中核高通自2023年收购西安展实检测工程有限公司以来的又一次无损检测业务版图拓展，将助力其进一步扩大细分领域市场份额，增强综合竞争实力，稳步提升行业市场地位与核心影响力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01763","BK1222"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-isotope.com","stockEarnings":[{"period":"1week","weight":-0.0976},{"period":"1month","weight":-0.045},{"period":"3month","weight":-0.1686},{"period":"6month","weight":-0.1358},{"period":"1year","weight":0.1852},{"period":"ytd","weight":-0.1315}],"compareEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":-0.1049},{"period":"3month","weight":-0.0914},{"period":"6month","weight":-0.1219},{"period":"1year","weight":-0.068},{"period":"ytd","weight":-0.1154}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国同辐股份有限公司是一家主要从事放射性药品、医用和工业用放射源产品的研究、开发、制造及销售的中国公司。该公司经营五个业务分部。药品分部主要提供各种显像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪，以及体外诊断试剂及药盒。放射源产品分部主要提供医疗、工业等领域用各种放射源产品及相关技术服务。辐照分部主要提供辐照灭菌服务。放射治疗设备及相关服务分部主要生产放疗设备。其他业务分部主要提供进口放射源、医用核素、进口放射性药品等产品的贸易服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.035439},{"month":2,"riseRate":0.5,"avgChangeRate":0.038778},{"month":3,"riseRate":0.375,"avgChangeRate":-0.034565},{"month":4,"riseRate":0.5,"avgChangeRate":-0.018502},{"month":5,"riseRate":0.5,"avgChangeRate":0.007801},{"month":6,"riseRate":0.5,"avgChangeRate":0.045726},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.02287},{"month":8,"riseRate":0.5,"avgChangeRate":0.038592},{"month":9,"riseRate":0.125,"avgChangeRate":-0.029077},{"month":10,"riseRate":0.625,"avgChangeRate":-0.037451},{"month":11,"riseRate":0.75,"avgChangeRate":0.064372},{"month":12,"riseRate":0.5,"avgChangeRate":0.001665}],"exchange":"SEHK","name":"中国同辐","nameEN":"CIRC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国同辐,01763,中国同辐股票,中国同辐股票老虎,中国同辐股票老虎国际,中国同辐行情,中国同辐股票行情,中国同辐股价,中国同辐股市,中国同辐股票价格,中国同辐股票交易,中国同辐股票购买,中国同辐股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}